Institution · Virginia Oncology Associates

Most cited papers from Virginia Oncology Associates

Virginia Oncology Associates

What are the most cited papers from Virginia Oncology Associates?

The most cited paper from Virginia Oncology Associates is "Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy" (Howard I. Scher, Karim S. Fizazi, Fred Saad et al., 2012), with 4,645 citations. Next come "Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial" (3,762) and "Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials" (1,802).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 68 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Howard I. Scher, Karim S. Fizazi, Fred Saad et al. · New England Journal of Medicine Open access	15 Aug 2012	4,645
2	Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial Jonathan E. Rosenberg et al. · The Lancet Open access	5 Mar 2016	3,762
3	Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials Robert Charles Doebele et al. · The Lancet Oncology Open access	11 Dec 2019	1,802
4	Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma Yohann Loriot et al. · New England Journal of Medicine Open access	24 Jul 2019	1,396
5	Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial Fairooz F. Kabbinavar, Joseph J. Schulz, Michael McCleod et al. · Journal of Clinical Oncology Open access	28 Feb 2005	936
6	Antiemetics: ASCO Guideline Update Paul Joseph Hesketh, Mark G. Kris, Ethan Basch et al. · Journal of Clinical Oncology	13 Jul 2020	478
7	Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement Jesús Esquivel et al. · Annals of Surgical Oncology	27 Oct 2006	433
8	Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial Shannon Neville Westin et al. · Journal of Clinical Oncology Open access256 authors	21 Oct 2023	370
9	Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies Gagan K. Gupta, Amber L. Collier, Dasom Lee et al. · Cancers Open access	24 Aug 2020	348
10	Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial Johann Sebastian De Bono, Niven Mehra, Giorgio V. Scagliotti et al. · The Lancet Oncology Open access	10 Aug 2021	291
11	Characterization of Long-Term Femoral-Head-Penetration Rates James E. Dowd, Christi J. Sychterz, Anthony M. Young et al. · Journal of Bone and Joint Surgery	Aug 2000	255
12	Feline Intracranial Neoplasia: Retrospective Review of 160 Cases (1985–2001) Mark T. Troxel, Charles H. Vite, Thomas J. Van Winkle et al. · Journal of Veterinary Internal Medicine	Nov 2003	253
13	Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results Asim Amin, Arkadiusz Zbigniew Dudek, Theodore F. Logan et al. · Journal for ImmunoTherapy of Cancer Open access	16 Apr 2015	217
14	Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis Erin Lynn Van Blarigan, Charles S. Fuchs, Donna Niedzwiecki et al. · JAMA Oncology Open access	12 Apr 2018	212
15	Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study Jesús Esquivel, Terence C. Chua, Alexander Stojadinovic et al. · Journal of Surgical Oncology Open access	23 Oct 2010	195
16	70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808 Jeffrey A. Bogart, James E. Herndon, Alan P. Lyss et al. · International Journal of Radiation OncologyBiologyPhysics	14 May 2004	179
17	Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study Shirish M. Gadgeel, Rimas Vincas Lukas, Jerome H. Goldschmidt et al. · Lung Cancer	19 Dec 2018	176
18	Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy John A. Glaspy, J. Jadeja, Glen R. Justice et al. · British Journal of Cancer Open access	Jul 2002	172
19	Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study Arlene Odelia Siefker-Radtke et al. · The Lancet Oncology Open access106 authors	11 Jan 2022	171
20	Failure of foot salvage in patients with end-stage renal disease after surgical revascularization Brad L Johnson, Marc H. Glickman, Dennis F. Bandyk et al. · Journal of Vascular Surgery Open access	Sep 1995	169
21	Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer Guru Sonpavde, Vsevolod Borisovich Matveev, John M. Burke et al. · Annals of Oncology Open access	23 Nov 2011	145
22	Thalidomide and rituximab in Waldenstrom macroglobulinemia Steven Peter Treon et al. · Blood Open access	20 Aug 2008	143
23	Laparoscopic Discectomy With Anterior Lumbar Interbody Fusion Hallett H. Mathews, Martin T. Evans, Harry Molligan et al. · Spine	Aug 1995	140
24	Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy Guru Sonpavde, Phillip Periman, Dirk M. Bernold et al. · Annals of Oncology Open access	25 Jul 2009	138
25	Magnetic Resonance Imaging Features of Feline Intracranial Neoplasia: Retrospective Analysis of 46 Cats Mark T. Troxel, Charles H. Vite, Christiane Massicotte et al. · Journal of Veterinary Internal Medicine Open access	Mar 2004	136
26	Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study Stephen E. Jones, Rufus Collea, Devchand Paul et al. · The Lancet Oncology	2 Sep 2013	135
27	Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer Matthew D. Galsky et al. · Journal of Clinical Oncology Open access	9 Apr 2020	133
28	Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth Ming Li, Laszlo George Radvanyi, Bingnan Yin et al. · Clinical Cancer Research Open access	5 Jul 2017	127
29	Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications Marc H. Glickman, Gordon K. Stokes, JOHN R. ROSS et al. · Journal of Vascular Surgery Open access	Sep 2001	120
30	Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial Antoinette R. Tan, Gail Shaw Wright, Anu R. Thummala et al. · The Lancet Oncology	28 Sep 2019	117
31	Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases Robert M. Barone, John E. Byfield, Paul B. Goldfarb et al. · Cancer	Sep 1982	117
32	A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer Matthew D. Galsky, Nicholas J. Vogelzang, Paul Conkling et al. · Clinical Cancer Research	12 Apr 2014	116
33	Risk of Stroke With E-Cigarette and Combustible Cigarette Use in Young Adults Tarang Parekh, Sahithi Pemmasani, Rupak Desai · American Journal of Preventive Medicine	7 Jan 2020	115
34	Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study Marwan Fakih et al. · EClinicalMedicine Open access	Apr 2023	114
35	Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes Matthew D. Galsky et al. · European Urology	13 Dec 2017	114
36	A Polymeric Sealant Inhibits Anastomotic Suture Hole Bleeding More Rapidly Than Gelfoam/Thrombin Results of a Randomized Controlled Trial Marc H. Glickman · Archives of Surgery	Mar 2002	112
37	Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer Aditya Bardia, Virginia Kaklamani, Sharon T. Wilks et al. · Journal of Clinical Oncology Open access	29 Jan 2021	111
38	Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: Immediate results and six-month follow-up of the multicenter AngioJet® registry José Antônio Silva, Stephen R. Ramee, Tyrone J. Collins et al. · Catheterization and Cardiovascular Diagnosis	Dec 1998	111
39	Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study Nicholas J. Vogelzang et al. · Clinical Genitourinary Cancer Open access	16 May 2020	107
40	Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study Joachim von Pawel, Rodolfo Eduardo Bordoni, Miyako Satouchi et al. · European Journal of Cancer	17 Dec 2018	107
41	VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancer Erika Paige Hamilton, Cynthia X. Ma, Michelino De Laurentiis et al. · Future Oncology Open access	29 Jul 2024	104
42	Qigong/tai chi for sleep and fatigue in prostate cancer patients undergoing radiotherapy: a randomized controlled trial Jennifer Leigh McQuade, Sarah Prinsloo, David Z. Chang et al. · Psycho-Oncology Open access	22 Aug 2016	96
43	PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label single‐arm phase 2 study Daniel Peter Petrylak et al. · The Prostate	19 Nov 2019	91
44	Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer Alison Katherine Conlin, Andrew David Seidman, Ariadne M. Bach et al. · Clinical Breast Cancer Open access	Aug 2010	89
45	Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance) Michael A. Fuchs, Kaori Sato, Donna Niedzwiecki et al. · PLoS ONE Open access	17 Jun 2014	85
46	Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer Daniel Peter Petrylak, Philip W. Kantoff, Nicholas J. Vogelzang et al. · The Prostate	20 Jan 2019	84
47	Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study Daniel Peter Petrylak, Yohann Loriot, David R. Shaffer et al. · Clinical Cancer Research	10 Feb 2021	83
48	The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice Natalie B. Simon, Michael A. Danso, Thomas Alberico et al. · Quality of Life Research	29 Jun 2017	82
49	A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy John A. Glaspy, J. Jadeja, Glen R. Justice et al. · British Journal of Cancer Open access	2001	81
50	A clinical review of pathophysiology, diagnosis, and treatment of uroabdomen in the dog and cat Jennifer R. Stafford, Joseph W. Bartges · Journal of Veterinary Emergency and Critical Care	Mar 2013	80

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.